首页> 外文会议>IEEE International Conference on Biomedical Robotics and Biomechatronics >A Novel Macrophage-Based Microrobot Bearing Multiple Smart Nanotherapeutics for Targeting and Drug Delivery to Solid Tumors* This research was supported by the Bio Medical Technology Development Program of the National Research Foundation (NRF) funded b
【24h】

A Novel Macrophage-Based Microrobot Bearing Multiple Smart Nanotherapeutics for Targeting and Drug Delivery to Solid Tumors* This research was supported by the Bio Medical Technology Development Program of the National Research Foundation (NRF) funded b

机译:一种用于固体瘤的靶向和药物递送多种智能纳米治疗方法的新型巨噬细胞的微毒液*本研究得到了国家研究基金会(NRF)资助的BIO和医疗技术开发计划的支持

获取原文

摘要

In this paper, we propose and evaluate a novel biological macrophage-based microrobot for applications in active targeting and treating of solid tumors. The microrobots are prepared by the phagocytosis of a mouse macrophage cell line with small size gold nanorods (sAuNRs) and anticancer drug (Doxorubicin) contained nanoliposomes (Dox-LPs). First, we synthesize sAuNRs with the average dimensions of 29 nm × 7 nm and high energy absorbance to 808 nm near-infrared (NIR) light. After that we prepare Dox-LPs having an average diameter of 145 nm and thermal sensitive property with over 65% of drug release after 60 min in a 43°C and pH 5.5 condition. After that, we fabricate the microrobots by co-incubation of sAuNRs and Dox-LPs with the macrophages. Experiments with confocal microscopy show that the nanotherapeutics can be readily engulfed by the macrophages. Finally, we evaluate the targeting characteristics of the microrobots to mouse breast cancer (4Tl) cells using a chemotactic test with a 3-D tumor spheroid resembling a solid tumor. Consequently, it is shown that the microrobots can successfully infiltrate into the tumor spheroid. Ultimately, the accompanying sAuNRs can be heated up to trigger the drug liberation from the thermal sensitive liposomes to kill microrobots and the tumor simultaneously.
机译:在本文中,我们提出并评估在主动靶向应用的新的生物基于巨噬细胞 - 微机器人和实体瘤的治疗。该微型机器人通过用小尺寸的金纳米棒(sAuNRs)小鼠巨噬细胞系的细胞吞噬制备和抗癌药物(多柔比星)含有纳米脂质体(Dox的LPS)。首先,我们用合成的29纳米×7纳米和高能量吸收的平均尺寸的近红外(NIR)光808纳米sAuNRs。之后,我们后在43℃60分钟和pH5.5的条件制备具有145纳米的平均直径和热敏感性质与药物释放超过65%的Dox-LPS。在那之后,我们制造的sAuNRs和阿霉素-LPS与巨噬细胞共培养的微型机器人。实验用共聚焦显微镜显示,纳米治疗剂可被巨噬细胞容易地吞噬。最后,我们评估微型机器人的小鼠乳腺癌靶向特性(的4T1)使用趋化试验用3-d的肿瘤细胞球状体类似实体瘤。因此,示出的是,微型机器人可以成功地渗透到肿瘤球状体。最终,伴随sAuNRs可以被加热到从热敏感脂质体触发药物释放以同时杀死微型机器人和肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号